{"protocolSection": {"identificationModule": {"nctId": "NCT00673075", "orgStudyIdInfo": {"id": "NEB-MD-06"}, "organization": {"fullName": "Forest Laboratories", "class": "INDUSTRY"}, "briefTitle": "The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease", "officialTitle": "Efficacy and Tolerability of Nebivolol Compared With Carvedilol in Patients With Coronary Artery Disease and Stage I or II Hypertension"}, "statusModule": {"statusVerifiedDate": "2010-09", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2008-05"}, "primaryCompletionDateStruct": {"date": "2009-09", "type": "ACTUAL"}, "studyFirstSubmitDate": "2008-04-29", "studyFirstSubmitQcDate": "2008-05-01", "studyFirstPostDateStruct": {"date": "2008-05-07", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2010-09-02", "resultsFirstSubmitQcDate": "2010-09-02", "resultsFirstPostDateStruct": {"date": "2010-09-28", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2010-09-02", "lastUpdatePostDateStruct": {"date": "2010-09-28", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"oldNameTitle": "John Whalen, MD, Executive Director, Clinical Development, Cardiovascular", "oldOrganization": "Forest Research Institute, a subsidiary of Forest Laboratories Inc."}, "leadSponsor": {"name": "Forest Laboratories", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "This study is being done to see if the blood pressure lowering effect of an approved drug nebivolol is comparable to that of another approved drug carvedilol for the treatment of hypertension in patients who have coronary artery disease."}, "conditionsModule": {"conditions": ["Hypertension", "Coronary Artery Disease"], "keywords": ["carvedilol", "Coreg (TM)", "hypertension", "blood pressure", "coronary artery disease", "Nebivolol", "BYSTOLIC (TM)"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 39, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "1", "type": "ACTIVE_COMPARATOR", "description": "Encapsulated Nebivolol", "interventionNames": ["Drug: Nebivolol"]}, {"label": "2", "type": "ACTIVE_COMPARATOR", "description": "Encapsulated Carvedilol", "interventionNames": ["Drug: Carvedilol"]}], "interventions": [{"type": "DRUG", "name": "Nebivolol", "description": "Encapsulated Nebivolol 5 mg, 10 mg, 20, mg, 40 mg total daily dosage, oral administration once daily", "armGroupLabels": ["1"], "otherNames": ["Bystolic"]}, {"type": "DRUG", "name": "Carvedilol", "description": "Encapsulated Carvedilol 12.5 mg, 25 mg, 50 mg total daily dosage, oral administration twice daily", "armGroupLabels": ["2"], "otherNames": ["Coreg"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Peripheral Diastolic Blood Pressure (DBP)", "description": "Peripheral diastolic blood pressure (DBP) at post-baseline (visit 13, week 18)", "timeFrame": "18 weeks post initiation of randomized treatment"}], "secondaryOutcomes": [{"measure": "Peripheral Systolic Blood Pressure (SBP)", "description": "Peripheral systolic blood pressure (SBP) at visit 13 (week 18)", "timeFrame": "18 weeks post initiation of randomized treatment"}, {"measure": "Proportion of Patients With Peripheral SBP <140 mm Hg and DBP <90 mm Hg at Week 18", "description": "Proportion of Patients with Peripheral SBP \\<140 mm Hg and DBP \\<90 mm Hg at Week 18", "timeFrame": "18 weeks post-treatment"}, {"measure": "Left Ventricular Ejection Fraction (LVEF) (%) at Week 18", "description": "Left ventricular ejection fraction (LVEF) (%) at Week 18", "timeFrame": "18 weeks post-treatment"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female ambulatory outpatients 18 to 85 of age at screening\n* Coronary artery disease as defined by: status post myocardial infarction (heart attack) greater than 14 days post event with no upper time limit (and followed by stress testing with additional imaging (echocardiographic or nuclear) within the 12 months prior to enrollment) and/or angiographic evidence of one or more major coronary arteries narrowing of greater than 50% and/or a history of percutaneous or surgical coronary revascularization greater than 4 months after that procedure at the time of enrollment.\n* Qualifying blood pressure criteria for study entry and for randomization\n* Willing to adhere to exercise stress (treadmill) tests\n\nExclusion Criteria:\n\n* Unstable angina within 7 days of screening\n* Potential coronary surgical/intervention within the next 6 months\n* Have any form of secondary hypertension\n* Have a history of hypersensitivity to nebivolol, metoprolol, carvedilol, or any beta blocker", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "80 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Tatjana Lukic, MD., M.Sc", "affiliation": "Forest Research Institute, Inc., a Subsidiary of Forest Laboratories, Inc.", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "Forest Investigative Site", "city": "Birmingham", "state": "Alabama", "zip": "35294", "country": "United States", "geoPoint": {"lat": 33.52066, "lon": -86.80249}}, {"facility": "Forest Investigative Site", "city": "Peoria", "state": "Arizona", "zip": "85381", "country": "United States", "geoPoint": {"lat": 33.5806, "lon": -112.23738}}, {"facility": "Forest Investigative Site", "city": "Buena Park", "state": "California", "zip": "90620", "country": "United States", "geoPoint": {"lat": 33.86751, "lon": -117.99812}}, {"facility": "Forest Investigative Site", "city": "Los Angeles", "state": "California", "zip": "90048", "country": "United States", "geoPoint": {"lat": 34.05223, "lon": -118.24368}}, {"facility": "Forest Investigative Site", "city": "Orange", "state": "California", "zip": "92868", "country": "United States", "geoPoint": {"lat": 33.78779, "lon": -117.85311}}, {"facility": "Forest Investigator Site", "city": "Santa Ana", "state": "California", "zip": "92705", "country": "United States", "geoPoint": {"lat": 33.74557, "lon": -117.86783}}, {"facility": "Forest Investigative Site", "city": "Guilford", "state": "Connecticut", "zip": "06437", "country": "United States", "geoPoint": {"lat": 41.28899, "lon": -72.68176}}, {"facility": "Forest Investigator Site", "city": "Coral Gables", "state": "Florida", "zip": "33134", "country": "United States", "geoPoint": {"lat": 25.72149, "lon": -80.26838}}, {"facility": "Forest Investigative Site", "city": "Daytona Beach", "state": "Florida", "zip": "32117", "country": "United States", "geoPoint": {"lat": 29.21081, "lon": -81.02283}}, {"facility": "Forest Investigator Site", "city": "Hollywood", "state": "Florida", "zip": "33021", "country": "United States", "geoPoint": {"lat": 26.0112, "lon": -80.14949}}, {"facility": "Forest Investigator Site", "city": "New Smyrna Beach", "state": "Florida", "zip": "32168", "country": "United States", "geoPoint": {"lat": 29.02582, "lon": -80.927}}, {"facility": "Forest Investigative Site", "city": "Orlando", "state": "Florida", "zip": "32803", "country": "United States", "geoPoint": {"lat": 28.53834, "lon": -81.37924}}, {"facility": "Forest Investigator Site", "city": "Winter Haven", "state": "Florida", "zip": "33880", "country": "United States", "geoPoint": {"lat": 28.02224, "lon": -81.73286}}, {"facility": "Forest Investigative Site", "city": "Chicago", "state": "Illinois", "zip": "60611", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "Forest Investigator Site", "city": "Indianapolis", "state": "Indiana", "zip": "46254", "country": "United States", "geoPoint": {"lat": 39.76838, "lon": -86.15804}}, {"facility": "Forest Investigator Site", "city": "Lafayette", "state": "Louisiana", "zip": "70503", "country": "United States", "geoPoint": {"lat": 30.22409, "lon": -92.01984}}, {"facility": "Forest Investigator Site", "city": "Auburn", "state": "Maine", "zip": "04210", "country": "United States", "geoPoint": {"lat": 44.09785, "lon": -70.23117}}, {"facility": "Forest Investigative Site", "city": "Pittsfield", "state": "Massachusetts", "zip": "01201", "country": "United States", "geoPoint": {"lat": 42.45008, "lon": -73.24538}}, {"facility": "Forest Investigator Site", "city": "Worcester", "state": "Massachusetts", "zip": "01655", "country": "United States", "geoPoint": {"lat": 42.26259, "lon": -71.80229}}, {"facility": "Forest Investigative Site", "city": "Detroit", "state": "Michigan", "zip": "48202", "country": "United States", "geoPoint": {"lat": 42.33143, "lon": -83.04575}}, {"facility": "Forest Investigative Site", "city": "Lansing", "state": "Michigan", "zip": "48910", "country": "United States", "geoPoint": {"lat": 42.73253, "lon": -84.55553}}, {"facility": "Forest Investigator Site", "city": "Las Vegas", "state": "Nevada", "zip": "89119", "country": "United States", "geoPoint": {"lat": 36.17497, "lon": -115.13722}}, {"facility": "Forest Investigative Site", "city": "Bronx", "state": "New York", "zip": "10451", "country": "United States", "geoPoint": {"lat": 40.84985, "lon": -73.86641}}, {"facility": "Forest Investigative Site", "city": "Bronx", "state": "New York", "zip": "10468", "country": "United States", "geoPoint": {"lat": 40.84985, "lon": -73.86641}}, {"facility": "Forest Investigative Site", "city": "Northport", "state": "New York", "zip": "11768", "country": "United States", "geoPoint": {"lat": 40.90093, "lon": -73.34317}}, {"facility": "Forest Investigative Site", "city": "Charlotte", "state": "North Carolina", "zip": "28211", "country": "United States", "geoPoint": {"lat": 35.22709, "lon": -80.84313}}, {"facility": "Forest Investigator Site", "city": "Lenoir", "state": "North Carolina", "zip": "28645", "country": "United States", "geoPoint": {"lat": 35.91402, "lon": -81.53898}}, {"facility": "Forest Investigative Site", "city": "Fargo", "state": "North Dakota", "zip": "58103", "country": "United States", "geoPoint": {"lat": 46.87719, "lon": -96.7898}}, {"facility": "Forest Investigative Site", "city": "Cincinnati", "state": "Ohio", "zip": "45219", "country": "United States", "geoPoint": {"lat": 39.12713, "lon": -84.51435}}, {"facility": "Forest Investigative Site", "city": "Lancaster", "state": "Pennsylvania", "zip": "17603", "country": "United States", "geoPoint": {"lat": 40.03788, "lon": -76.30551}}, {"facility": "Forest Investigative Site", "city": "Charleston", "state": "South Carolina", "zip": "29401", "country": "United States", "geoPoint": {"lat": 32.77657, "lon": -79.93092}}, {"facility": "Forest Investigator Site", "city": "Florence", "state": "South Carolina", "zip": "29501", "country": "United States", "geoPoint": {"lat": 34.19543, "lon": -79.76256}}, {"facility": "Forest Investigative Site", "city": "Cleveland", "state": "Tennessee", "zip": "37312", "country": "United States", "geoPoint": {"lat": 35.15952, "lon": -84.87661}}, {"facility": "Forest Investigative Site", "city": "Carrollton", "state": "Texas", "zip": "75006", "country": "United States", "geoPoint": {"lat": 32.95373, "lon": -96.89028}}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "All patients went through a 4-week, single blind, metoprolol run-in phase before randomization.", "recruitmentDetails": "The recruitment period was April 2008 to May 2009 at 35 US locations.", "groups": [{"id": "FG000", "title": "Nebivolol", "description": "Encapsulated Nebivolol"}, {"id": "FG001", "title": "Carvedilol", "description": "Encapsulated Carvedilol"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "21"}, {"groupId": "FG001", "numSubjects": "18"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "12"}, {"groupId": "FG001", "numSubjects": "11"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "9"}, {"groupId": "FG001", "numSubjects": "7"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Nebivolol", "description": "Encapsulated Nebivolol"}, {"id": "BG001", "title": "Carvedilol", "description": "Encapsulated Carvedilol"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "21"}, {"groupId": "BG001", "value": "18"}, {"groupId": "BG002", "value": "39"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "12"}, {"groupId": "BG001", "value": "9"}, {"groupId": "BG002", "value": "21"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "9"}, {"groupId": "BG001", "value": "9"}, {"groupId": "BG002", "value": "18"}]}]}]}, {"title": "Age Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "60.6", "spread": "10.5"}, {"groupId": "BG001", "value": "66.6", "spread": "10.3"}, {"groupId": "BG002", "value": "63.4", "spread": "10.7"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "7"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "20"}, {"groupId": "BG001", "value": "12"}, {"groupId": "BG002", "value": "32"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "21"}, {"groupId": "BG001", "value": "18"}, {"groupId": "BG002", "value": "39"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Peripheral Diastolic Blood Pressure (DBP)", "description": "Peripheral diastolic blood pressure (DBP) at post-baseline (visit 13, week 18)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mmHg", "timeFrame": "18 weeks post initiation of randomized treatment", "groups": [{"id": "OG000", "title": "Nebivolol", "description": "Encapsulated Nebivolol"}, {"id": "OG001", "title": "Carvedilol", "description": "Encapsulated Carvedilol"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "12"}]}], "classes": [{"title": "Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "81.1", "spread": "1.7"}, {"groupId": "OG001", "value": "78.2", "spread": "1.8"}]}]}, {"title": "Post-baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "78.0", "spread": "2.4"}, {"groupId": "OG001", "value": "79.3", "spread": "2.6"}]}]}]}, {"type": "SECONDARY", "title": "Peripheral Systolic Blood Pressure (SBP)", "description": "Peripheral systolic blood pressure (SBP) at visit 13 (week 18)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mmHg", "timeFrame": "18 weeks post initiation of randomized treatment", "groups": [{"id": "OG000", "title": "Nebivolol", "description": "Encapsulated Nebivolol"}, {"id": "OG001", "title": "Carvedilol", "description": "Encapsulated Carvedilol"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "12"}]}], "classes": [{"title": "Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "135.1", "spread": "2.5"}, {"groupId": "OG001", "value": "136.9", "spread": "2.4"}]}]}, {"title": "Post-Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "129.6", "spread": "3.7"}, {"groupId": "OG001", "value": "137.3", "spread": "4.4"}]}]}]}, {"type": "SECONDARY", "title": "Proportion of Patients With Peripheral SBP <140 mm Hg and DBP <90 mm Hg at Week 18", "description": "Proportion of Patients with Peripheral SBP \\<140 mm Hg and DBP \\<90 mm Hg at Week 18", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "18 weeks post-treatment", "groups": [{"id": "OG000", "title": "Nebivolol", "description": "Encapsulated Nebivolol"}, {"id": "OG001", "title": "Carvedilol", "description": "Encapsulated Carvedilol"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "12"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "11"}, {"groupId": "OG001", "value": "5"}]}]}]}, {"type": "SECONDARY", "title": "Left Ventricular Ejection Fraction (LVEF) (%) at Week 18", "description": "Left ventricular ejection fraction (LVEF) (%) at Week 18", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "percentage", "timeFrame": "18 weeks post-treatment", "groups": [{"id": "OG000", "title": "Nebivolol", "description": "Encapsulated Nebivolol"}, {"id": "OG001", "title": "Carvedilol", "description": "Encapsulated Carvedilol"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "12"}, {"groupId": "OG001", "value": "12"}]}], "classes": [{"title": "Baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "61.43", "spread": "0.562"}, {"groupId": "OG001", "value": "60.442", "spread": "1.125"}]}]}, {"title": "Post baseline", "categories": [{"measurements": [{"groupId": "OG000", "value": "61.93", "spread": "0.503"}, {"groupId": "OG001", "value": "60.775", "spread": "0.614"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "The adverse event reporting timeframe was 16 months - from June,2008 until October, 2009.", "eventGroups": [{"id": "EG000", "title": "Nebivolol Combined Up-Titration and Stable-dose", "description": "Encapsulated Nebivolol Combined Up-Titration and Stable-Dose Periods", "seriousNumAffected": 1, "seriousNumAtRisk": 21, "otherNumAffected": 9, "otherNumAtRisk": 21}, {"id": "EG001", "title": "Carvedilol Combined Up-Titration and Stable-dose", "description": "Encapsulated Carvedilol Combined Up-Titration and Stable-Dose Periods", "seriousNumAffected": 0, "seriousNumAtRisk": 18, "otherNumAffected": 10, "otherNumAtRisk": 18}, {"id": "EG002", "title": "Nebivolol Down-Titration", "description": "Encapsulated Nebivolol Down-Titration Period", "seriousNumAffected": 0, "seriousNumAtRisk": 12, "otherNumAffected": 1, "otherNumAtRisk": 12}, {"id": "EG003", "title": "Carvedilol Down-Titration", "description": "Encapsulated Carvedilol Down-Titration Period", "seriousNumAffected": 0, "seriousNumAtRisk": 11, "otherNumAffected": 1, "otherNumAtRisk": 11}], "seriousEvents": [{"term": "Cerebrovascular accident", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}], "otherEvents": [{"term": "Cerumen impaction", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Hyperthyroidism", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Nausea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 11}]}, {"term": "Constipation", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Painful defaecatio", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Chest pain", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Chest discomfort", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Fatigue", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Oedema peripheral", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Sinusitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Cellulitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Lower respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Contusion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Excoriation", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Wound", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Dehydration", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Arthralgia", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Arthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Haemarthrosis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Musculoskeletal chest pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Musculoskeletal pain", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Pain in extremity", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Dizziness postural", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Paraesthesia", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Anxiety", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Rhinitis allergic", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Upper respiratory tract congestion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Rosacea", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Haematoma", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Otitis externa", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 11}]}, {"term": "Epididymitis", "organSystem": "Reproductive system and breast disorders", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 0, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 1, "numAtRisk": 11}]}, {"term": "Tinea infecton", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 12.1", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 21}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 18}, {"groupId": "EG002", "numAffected": 1, "numAtRisk": 12}, {"groupId": "EG003", "numAffected": 0, "numAtRisk": 11}]}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "The study was terminated early because of difficulties with enrollment. Only 39 out of 160 planned patients were randomized."}, "certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "Sponsor can review results communications prior to public release \\& can embargo communications re: results for 60 days from time submitted to sponsor for review. PI shall not disclose sponsor's confidential information. Upon sponsor's request, PI shall delete any proprietary info \\& shall not include raw data in the publication. On sponsor's request, PI shall delay submission for any pub while sponsor files patent applications. Any publication will give recognition to Sponsor's support."}, "pointOfContact": {"title": "John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism", "organization": "Forest Laboratories", "email": "John.Whalen@frx.com", "phone": "1-201-427-8259"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-26"}, "conditionBrowseModule": {"meshes": [{"id": "D000006973", "term": "Hypertension"}, {"id": "D000003324", "term": "Coronary Artery Disease"}, {"id": "D000017202", "term": "Myocardial Ischemia"}, {"id": "D000003327", "term": "Coronary Disease"}], "ancestors": [{"id": "D000014652", "term": "Vascular Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}, {"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000001161", "term": "Arteriosclerosis"}, {"id": "D000001157", "term": "Arterial Occlusive Diseases"}], "browseLeaves": [{"id": "M10024", "name": "Hypertension", "asFound": "Hypertension", "relevance": "HIGH"}, {"id": "M6546", "name": "Coronary Artery Disease", "asFound": "Coronary Artery Disease", "relevance": "HIGH"}, {"id": "M19506", "name": "Myocardial Ischemia", "asFound": "Coronary Artery Disease", "relevance": "HIGH"}, {"id": "M6549", "name": "Coronary Disease", "asFound": "Coronary Artery Disease", "relevance": "HIGH"}, {"id": "M10543", "name": "Ischemia", "relevance": "LOW"}, {"id": "M17400", "name": "Vascular Diseases", "relevance": "LOW"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "M4469", "name": "Arteriosclerosis", "relevance": "LOW"}, {"id": "M4465", "name": "Arterial Occlusive Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000077261", "term": "Carvedilol"}, {"id": "D000068577", "term": "Nebivolol"}], "ancestors": [{"id": "D000000319", "term": "Adrenergic beta-Antagonists"}, {"id": "D000018674", "term": "Adrenergic Antagonists"}, {"id": "D000018663", "term": "Adrenergic Agents"}, {"id": "D000018377", "term": "Neurotransmitter Agents"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000000959", "term": "Antihypertensive Agents"}, {"id": "D000000975", "term": "Antioxidants"}, {"id": "D000020011", "term": "Protective Agents"}, {"id": "D000002121", "term": "Calcium Channel Blockers"}, {"id": "D000049990", "term": "Membrane Transport Modulators"}, {"id": "D000077264", "term": "Calcium-Regulating Hormones and Agents"}, {"id": "D000014665", "term": "Vasodilator Agents"}, {"id": "D000058668", "term": "Adrenergic alpha-1 Receptor Antagonists"}, {"id": "D000000317", "term": "Adrenergic alpha-Antagonists"}, {"id": "D000058665", "term": "Adrenergic beta-1 Receptor Agonists"}, {"id": "D000000318", "term": "Adrenergic beta-Agonists"}, {"id": "D000000322", "term": "Adrenergic Agonists"}], "browseLeaves": [{"id": "M1718", "name": "Carvedilol", "asFound": "Depressive Disorder", "relevance": "HIGH"}, {"id": "M276", "name": "Nebivolol", "asFound": "Total Knee Replacement", "relevance": "HIGH"}, {"id": "M3671", "name": "Adrenergic beta-Antagonists", "relevance": "LOW"}, {"id": "M20746", "name": "Adrenergic Agents", "relevance": "LOW"}, {"id": "M20755", "name": "Adrenergic Antagonists", "relevance": "LOW"}, {"id": "M20504", "name": "Neurotransmitter Agents", "relevance": "LOW"}, {"id": "M4277", "name": "Antihypertensive Agents", "relevance": "LOW"}, {"id": "M4292", "name": "Antioxidants", "relevance": "LOW"}, {"id": "M21869", "name": "Protective Agents", "relevance": "LOW"}, {"id": "M5398", "name": "Calcium, Dietary", "relevance": "LOW"}, {"id": "M5381", "name": "Calcium", "relevance": "LOW"}, {"id": "M5384", "name": "Calcium Channel Blockers", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M17412", "name": "Vasodilator Agents", "relevance": "LOW"}, {"id": "M29194", "name": "Adrenergic alpha-1 Receptor Antagonists", "relevance": "LOW"}, {"id": "M3669", "name": "Adrenergic alpha-Antagonists", "relevance": "LOW"}, {"id": "M3670", "name": "Adrenergic beta-Agonists", "relevance": "LOW"}, {"id": "M3673", "name": "Adrenergic Agonists", "relevance": "LOW"}], "browseBranches": [{"abbrev": "AnAg", "name": "Antihypertensive Agents"}, {"abbrev": "ChanBlk", "name": "Channel Blockers"}, {"abbrev": "VaDiAg", "name": "Vasodilator Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "BDCA", "name": "Bone Density Conservation Agents"}]}}, "hasResults": true}